As a key factor affecting obesity-induced insulin resistance and intestinal flora-mediated inflammation, activating the SM metabolic pathway can promote the phosphorylation of IKK, which activates the NF-κB pathway by phosphorylating IκBα [65]. This evidence concerns the gene NFKB1 and obesity disorder.